Clinical Trial Results

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more

RECRUITING

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

PHASE1INTERVENTIONAL Maitland, Florida +4 more

RECRUITING

An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease

PHASE1INTERVENTIONAL Maitland, Florida

RECRUITING

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

PHASE3INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

PHASE2INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

Open-label Extension Study in Participants With Early Alzheimer's Disease

PHASE2INTERVENTIONAL Maitland, Florida +4 more

RECRUITING

A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

PHASE2INTERVENTIONAL Maitland, Florida +4 more

RECRUITING

Clinical Trial on Agitation in Alzheimer's Dementia

PHASE2INTERVENTIONAL Maitland, Florida +4 more

RECRUITING

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

PHASE1INTERVENTIONAL Los Alamitos, California +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

PHASE3INTERVENTIONAL Fullerton, California +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

PHASE3INTERVENTIONAL Long Beach, California +4 more

RECRUITING

A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration

PHASE1INTERVENTIONAL Anaheim, California +4 more

RECRUITING

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

PHASE2INTERVENTIONAL Oakland, California +4 more

RECRUITING

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

PHASE4INTERVENTIONAL Irvine, California +4 more

RECRUITING